JILL SCOTT: Open Payments
NPI 1124428222 · ANOKA, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 78 payments from 15 companies in 2025. Trend: 2023 $1,209 · 2024 $1,072 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $250 |
| ABBVIE INC. | 18 | $201 |
| E.R. Squibb & Sons, L.L.C. | 11 | $141 |
| Alkermes, Inc. | 5 | $95 |
| Axsome Therapeutics, Inc. | 5 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
| Almatica Pharma LLC | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $43 |
| Corium, LLC | 2 | $41 |
Products named: CAPLYTA, VRAYLAR, COBENFY, REXULTI, ARISTADA, INVEGA SUSTENNA, LOREEV XR, Auvelity.
Industry payments across MN — which companies pay providers there.
